This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

B3's portfolio power poses challenge for CRDC acquisition in Brazil

By Maria Júlia Baumert ( September 1, 2026, 19:36 GMT | Comment) -- Brazilian stock exchange operator B3's acquisition of credit registry CRDC and a related partnership with the São Paulo Commercial Association are scheduled for a Wednesday vote in Brazil's competition Tribunal. The ruling could indicate how the authority will address concerns about B3's broad portfolio and ability to leverage its existing market power, with behavioral remedies likely to play a central role in the decision.Brazilian stock exchange operator B3's acquisition of a credit registry and a related partnership with the São Paulo Commercial Association are scheduled for a Wednesday vote in Brazil's competition Tribunal. The ruling could indicate how the authority will address concerns about B3's broad portfolio and ability to leverage its existing market power, with behavioral remedies likely to play a central role in the decision....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login